![](/img/cover-not-exists.png)
A comment on “A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia” by Zhou et al.
Demirci, Ufuk, Ümit, Elif Gülsüm, Demir, Ahmet MuzafferJournal:
American Journal of Hematology
DOI:
10.1002/ajh.25740
Date:
January, 2020
File:
PDF, 217 KB
2020